The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the safe and effective use of oral ciclosporin in the field of dermatology. The document aims to: offer an appraisal of all relevant literature since 1970 focusing on any key developments address important, practical clinical questions relating to the primary guideline objective provide guideline recommendations and, where appropriate, with some health economic implications discuss potential developments and future directions The guideline is presented as a detailed review with highlighted recommendations for practical use in the clinic (see section 14), in addition to an updated Patient Information Leaflet (PIL; available on the BAD website, www.bad.org.uk/leaflets). This article is protected by copyright. All rights reserved.
No takes yet. Share an insight, caveat, or question.
Berth‐Jones et al. (2019) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: